{"id":"https://genegraph.clinicalgenome.org/r/5ece3f9a-11b5-4654-8014-edc1edf5dba5v2.1","type":"EvidenceStrengthAssertion","dc:description":"*NKX2.5* was first reported in relation to autosomal dominant NKX2.5-related congenital, conduction and myopathic heart disease in 1998 (Schott et al., PMID:9651244) including congenital heart disease entities: Atrial septal defect 7, with or without AV conduction defects (OMIM:108900), Conotruncal heart malformations, variable (OMIM:217095), Hypoplastic left heart syndrome 2 (OMIM:614435), Tetralogy of Fallot (OMIM:187500), Ventricular septal defect 3 (OMIM:614432). Since then, more than 26 unique variants (missense, nonsense, frameshift, deletions) across 18 papers have reported cases of a similar phenotype including congenital heart disease (predominantly ASD), AV block and later onset dilated cardiomyopathy and/or hypertrabeculation with predisposition to atrial and ventricular arrhythmias (PMIDs 38670870, 36609421, 34277740, 33082984, 31654754, 30471092, 30479953, 30354339, 28690296, 26679770, 27855642, 25503402, 24880466, 23661673, 20456451, 15810002, 14607454, 10587520 ). Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we found no difference in molecular mechanisms or inheritance pattern and these phenotypes have been lumped. Phenotype is variable within families and individuals may have only some of these features. Variants causing this phenotype appear to be either truncating or missense within the homeodomain. The relevance of non-truncating variants outside of the homeodomain is unclear. This gene-disease relationship is supported by three mouse models, functional alteration data, and protein interaction data (PMIDs: 28352650, 18689573, 7628699, 26146939, 27154817). In summary, *NKX2.5* is definitively associated with autosomal dominant NKX2.5-related congenital, conduction and myopathic heart disease. This has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time. This classification was approved by the ClinGen Congenital Heart Disease GCEP on the meeting date 3/7/2023 (SOP Version 9), and the summary was updated by the ClinGen Hereditary Cardiovascular Disease GCEP after meeting on 11/7/2024 to expand detail on the cardiomyopathy and arrhythmia aspects of the phenotype.\n.","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/5ece3f9a-11b5-4654-8014-edc1edf5dba5","GCISnapshot":"https://genegraph.clinicalgenome.org/r/c429ebe5-43ec-40e7-9d73-55bbbb44f6d1","calculatedEvidenceStrength":"Definitive","contributions":[{"agent":"https://genegraph.clinicalgenome.org/agent/10104","role":"SecondaryContributor"},{"id":"https://genegraph.clinicalgenome.org/r/c429ebe5-43ec-40e7-9d73-55bbbb44f6d1_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10130","date":"2025-03-25T18:37:54.388Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/c429ebe5-43ec-40e7-9d73-55bbbb44f6d1_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10130","date":"2024-11-07T17:00:00.000Z","role":"Approver"}],"curationReasons":["ErrorClarification"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c429ebe5-43ec-40e7-9d73-55bbbb44f6d1_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0fdb64b7-5741-4fdd-acb9-cede0e517426","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0fdb64b7-5741-4fdd-acb9-cede0e517426_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30471092","allele":{"id":"https://genegraph.clinicalgenome.org/r/25977a15-68cd-4d6f-a2c7-98071f7b8102","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004387.4(NKX2-5):c.604C>G (p.Leu202Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA362161512"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/d4f2bc25-afa1-4241-acee-502a931d8f53","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d4f2bc25-afa1-4241-acee-502a931d8f53_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20456451","allele":{"id":"https://genegraph.clinicalgenome.org/r/283baf24-d310-49bb-912c-636a68b51494","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004387.4(NKX2-5):c.762del (p.Ala255ProfsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2580610985"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/104db72c-cda9-40d2-a80d-c5b8c4d4537e","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/104db72c-cda9-40d2-a80d-c5b8c4d4537e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16896344","allele":{"id":"https://genegraph.clinicalgenome.org/r/eee64d1c-af8e-45d1-93f9-d4f80016c1a4","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004387.4(NKX2-5):c.768T>G (p.Tyr256Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10586352"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/e53dd1a5-3e82-485c-968c-20f19a3c3090","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e53dd1a5-3e82-485c-968c-20f19a3c3090_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34214246","allele":{"id":"https://genegraph.clinicalgenome.org/r/bb5fce83-70ea-4e8a-a9d1-0c9a1a486ff0","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004387.4(NKX2-5):c.443C>A (p.Ala148Glu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA279927"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/e53dd1a5-3e82-485c-968c-20f19a3c3090_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Transactivation study using Nppa and Actc1 promoters showed impaired activity\n","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/1068eddc-4ccb-458a-83c5-c49a762191a6","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1068eddc-4ccb-458a-83c5-c49a762191a6_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9651244","allele":{"id":"https://genegraph.clinicalgenome.org/r/6f9de694-d7fa-43c9-9523-fed0c3c0b9e6","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004387.4(NKX2-5):c.508C>T (p.Gln170Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA212654"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/1d2e3983-a388-46eb-9039-05d9b2450855","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1d2e3983-a388-46eb-9039-05d9b2450855_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9651244","allele":{"id":"https://genegraph.clinicalgenome.org/r/b9aa670a-bb4e-4414-8232-d7d031779905","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004387.4(NKX2-5):c.533C>T (p.Thr178Met)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA212653"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/b5bd0325-0470-460f-bdce-912f993a0582","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b5bd0325-0470-460f-bdce-912f993a0582_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34214246","allele":{"id":"https://genegraph.clinicalgenome.org/r/b249ee65-e85e-4af3-a921-f94409c936d9","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004387.4(NKX2-5):c.391G>A (p.Glu131Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA279909"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/b5bd0325-0470-460f-bdce-912f993a0582_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Transactivation study using Nppa and Actc1 promoters showed impaired activity\n","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/45452cb1-049d-4335-83f8-f0e570640da8","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/45452cb1-049d-4335-83f8-f0e570640da8_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23661673","allele":{"id":"https://genegraph.clinicalgenome.org/r/b3b9d7c0-a19f-4563-b63b-14eb3a799816","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004387.4(NKX2-5):c.552C>G (p.Ile184Met)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA362161630"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/45452cb1-049d-4335-83f8-f0e570640da8_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"in vitro analysis demonstrated a striking increase in protein expression when transfected into COS-7 cells or HL-1 cardiomyocytes because of reduced degradation by the Ubiquitin-proteasome system. In functional assays, DNA-binding activity of I184M was reduced, resulting in impaired activation of target genes despite increased expression levels of mutant protein","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/8c8b43bc-ce36-4574-984f-c1d9bd90341c","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8c8b43bc-ce36-4574-984f-c1d9bd90341c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11714651","allele":{"id":"https://genegraph.clinicalgenome.org/r/fb620865-29a6-44ef-96e3-776f490b110c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004387.4(NKX2-5):c.656C>T (p.Ala219Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA248607"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/7bcdccfa-2082-41ec-b267-22e8644a09b0","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7bcdccfa-2082-41ec-b267-22e8644a09b0_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20456451","allele":{"id":"https://genegraph.clinicalgenome.org/r/9dd79b90-8efe-4586-9f2f-8d3c543a1e1b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004387.4(NKX2-5):c.569G>T (p.Arg190Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA362161589"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/418a3a27-04b9-49af-90b6-6516bda761e5","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/418a3a27-04b9-49af-90b6-6516bda761e5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34214246","allele":{"id":"https://genegraph.clinicalgenome.org/r/8df03006-6c9c-4e60-b16f-e16db7b84432","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004387.4(NKX2-5):c.182C>G (p.Ala61Gly)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA279938"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/418a3a27-04b9-49af-90b6-6516bda761e5_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Transactivation study using Nppa and Actc1 promoters showed impaired activity\n","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/f923c6a9-4110-41f0-a5a4-db7a153cd459","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f923c6a9-4110-41f0-a5a4-db7a153cd459_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14607454","allele":{"id":"https://genegraph.clinicalgenome.org/r/00028d40-f298-4f06-9451-ac393c458006","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004387.4(NKX2-5):c.380C>A (p.Ala127Glu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA212678"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/13cc8993-0eb6-4105-b20f-f203eb2d550a","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/13cc8993-0eb6-4105-b20f-f203eb2d550a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9651244","allele":{"id":"https://genegraph.clinicalgenome.org/r/e570cdaf-90a8-48bd-825b-5078580d7eb4","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004387.4(NKX2-5):c.592C>T (p.Gln198Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA212656"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/2e996ed8-e6aa-4b7a-b3cc-d46de8f2b6ee","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2e996ed8-e6aa-4b7a-b3cc-d46de8f2b6ee_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15810002","allele":{"id":"https://genegraph.clinicalgenome.org/r/68a68226-5369-4352-bbfa-6821db5ef4c8","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004387.4(NKX2-5):c.568C>T (p.Arg190Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA212658"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/6d64a346-ae5f-4c58-9d03-b5e168932c15","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6d64a346-ae5f-4c58-9d03-b5e168932c15_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20659440","allele":{"id":"https://genegraph.clinicalgenome.org/r/5f2c6432-6663-41e2-964e-53e5044340a3","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004387.4(NKX2-5):c.769C>G (p.Pro257Ala)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA212681"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/33146211-2ab8-41fa-a0e2-66dfae3b6ad8","type":"EvidenceLine","dc:description":"Recurrent variant","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/33146211-2ab8-41fa-a0e2-66dfae3b6ad8_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15810002","allele":{"id":"https://genegraph.clinicalgenome.org/r/b9aa670a-bb4e-4414-8232-d7d031779905"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/c429ebe5-43ec-40e7-9d73-55bbbb44f6d1_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ba2e4a14-c469-4643-bc96-00ae6ef156c2_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9651244","rdfs:label":"Family MBX","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/ba2e4a14-c469-4643-bc96-00ae6ef156c2","type":"Family","rdfs:label":"Family MBX","member":{"id":"https://genegraph.clinicalgenome.org/r/b9f2a2b8-f03e-4e8f-abdb-6ecd10e862fa","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9651244","rdfs:label":"Proband IV-1","allele":{"id":"https://genegraph.clinicalgenome.org/r/e570cdaf-90a8-48bd-825b-5078580d7eb4"},"detectionMethod":"They amplified and sequenced both NKX2-5 exons in DNA samples from two affected individuals in each study family. Each sequence variant was independently confirmed by restriction enzyme digestion or oligonucleotide-specific hybridization. ","firstTestingMethod":"PCR","secondTestingMethod":"Restriction digest","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/13cc8993-0eb6-4105-b20f-f203eb2d550a_variant_evidence_item"}}},"meetsInclusionCriteria":false,"phenotypePositiveAllelePositive":3,"phenotypes":["obo:HP_0001631","obo:HP_0001678"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/b9f2a2b8-f03e-4e8f-abdb-6ecd10e862fa"}},{"id":"https://genegraph.clinicalgenome.org/r/8bfb8a4c-4c72-4f3d-8bcb-78c409556edf_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9651244","rdfs:label":"Family MBT","estimatedLodScore":0.9,"family":{"id":"https://genegraph.clinicalgenome.org/r/8bfb8a4c-4c72-4f3d-8bcb-78c409556edf","type":"Family","rdfs:label":"Family MBT","member":{"id":"https://genegraph.clinicalgenome.org/r/35857b43-087c-480a-9619-ffeec29b22d5","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9651244","rdfs:label":"Proband IV-7","allele":{"id":"https://genegraph.clinicalgenome.org/r/6f9de694-d7fa-43c9-9523-fed0c3c0b9e6"},"detectionMethod":"They amplified and sequenced both NKX2-5 exons in DNA samples from two affected individuals in each study family. Each sequence variant was independently confirmed by restriction enzyme digestion or oligonucleotide-specific hybridization","firstTestingMethod":"PCR","phenotypes":["obo:HP_0001631","obo:HP_0001678"],"secondTestingMethod":"Restriction digest","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/1068eddc-4ccb-458a-83c5-c49a762191a6_variant_evidence_item"}}},"meetsInclusionCriteria":false,"phenotypePositiveAllelePositive":4,"phenotypes":["obo:HP_0001678","obo:HP_0001631"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/35857b43-087c-480a-9619-ffeec29b22d5"}},{"id":"https://genegraph.clinicalgenome.org/r/5cc1195d-6b62-4729-a7c7-1a70676e5016_proband_segregation","type":"FamilyCosegregation","dc:description":"Genome-wide linkage analyses performed in family MXP demonstrated linkage to locus D5S1456 [logarithm of the odds (LOD) score = 3.91, θ = 0]","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9651244","rdfs:label":"Family MXP","estimatedLodScore":1.81,"family":{"id":"https://genegraph.clinicalgenome.org/r/5cc1195d-6b62-4729-a7c7-1a70676e5016","type":"Family","rdfs:label":"Family MXP","member":{"id":"https://genegraph.clinicalgenome.org/r/55a5f597-6660-4626-83df-7d830fed8f32","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9651244","rdfs:label":"Proband IV-13","allele":{"id":"https://genegraph.clinicalgenome.org/r/b9aa670a-bb4e-4414-8232-d7d031779905"},"detectionMethod":"They amplified and sequenced both NKX2-5 exons in DNA samples from two affected individuals in each study family. Each sequence variant was independently confirmed by restriction enzyme digestion or oligonucleotide-specific hybridization","firstTestingMethod":"PCR","phenotypes":["obo:HP_0001631","obo:HP_0001678"],"secondTestingMethod":"Restriction digest","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/1d2e3983-a388-46eb-9039-05d9b2450855_variant_evidence_item"}}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":6,"phenotypes":["obo:HP_0001631","obo:HP_0001678"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/55a5f597-6660-4626-83df-7d830fed8f32"},"publishedLodScore":3.91,"sequencingMethod":{"id":"cg:AllGenesSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/1c11598c-e6c0-459b-b5e5-143c92cb8ebe_proband_segregation","type":"FamilyCosegregation","dc:description":"Linkage between the disease and each mutation was assessed in the study families, assuming an allele frequency of 0.01.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9651244","rdfs:label":"Family MBF","estimatedLodScore":1.2,"family":{"id":"https://genegraph.clinicalgenome.org/r/1c11598c-e6c0-459b-b5e5-143c92cb8ebe","type":"Family","rdfs:label":"Family MBF","member":{"id":"https://genegraph.clinicalgenome.org/r/215026c0-565d-4e36-b75c-4dbf1fc00e53","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9651244","rdfs:label":"Proband V-4","allele":{"id":"https://genegraph.clinicalgenome.org/r/b9aa670a-bb4e-4414-8232-d7d031779905"},"detectionMethod":"They amplified and sequenced both NKX2-5 exons in DNA samples from two affected individuals in each study family. Each sequence variant was independently confirmed by restriction enzyme digestion or oligonucleotide-specific hybridization","firstTestingMethod":"PCR","phenotypes":["obo:HP_0001631","obo:HP_0001678"],"secondTestingMethod":"Restriction digest","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/146ccb1a-cfdb-49e1-89b1-05cb140a6a17_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9651244","allele":{"id":"https://genegraph.clinicalgenome.org/r/b9aa670a-bb4e-4414-8232-d7d031779905"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":5,"phenotypes":["obo:HP_0001631","obo:HP_0001678"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/215026c0-565d-4e36-b75c-4dbf1fc00e53"},"publishedLodScore":1.23,"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":2.6},{"id":"https://genegraph.clinicalgenome.org/r/6c2c434a-9522-4247-b668-26ddbd4d501d","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6c2c434a-9522-4247-b668-26ddbd4d501d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14607454","allele":{"id":"https://genegraph.clinicalgenome.org/r/918b43bb-19df-465f-83ce-3c529dda3fb2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004387.4(NKX2-5):c.701_702insTCCCT (p.Ala235ProfsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2580610986"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/1829d1b2-7384-4578-87ac-fc88b155114d","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1829d1b2-7384-4578-87ac-fc88b155114d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15810002","allele":{"id":"https://genegraph.clinicalgenome.org/r/00d0bc1c-66a3-48d9-b8d6-748cecf1834f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004387.4(NKX2-5):c.262del (p.Ala88ProfsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA212912"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/146ccb1a-cfdb-49e1-89b1-05cb140a6a17","type":"EvidenceLine","dc:description":"Recurrent variant not scored","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/146ccb1a-cfdb-49e1-89b1-05cb140a6a17_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/f1c326d4-3e55-46d6-bada-2466919e4ac9","type":"EvidenceLine","dc:description":"Recurrent variant","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f1c326d4-3e55-46d6-bada-2466919e4ac9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34214246","allele":{"id":"https://genegraph.clinicalgenome.org/r/b249ee65-e85e-4af3-a921-f94409c936d9"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/f1c326d4-3e55-46d6-bada-2466919e4ac9_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Transactivation study using Nppa and Actc1 promoters showed impaired activity\n","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/08a753d7-44d1-4f5c-a70a-97802acdb99d","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/08a753d7-44d1-4f5c-a70a-97802acdb99d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21165553","allele":{"id":"https://genegraph.clinicalgenome.org/r/3e39dc59-bd50-4f20-b165-8de8a17fa348","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004387.4(NKX2-5):c.175C>G (p.Pro59Ala)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA212680"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/7af7547d-aff3-433b-8aae-744872213891","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7af7547d-aff3-433b-8aae-744872213891_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14607454","allele":{"id":"https://genegraph.clinicalgenome.org/r/61c04ae7-6edd-427a-b805-0c331b1e73b6","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004387.4(NKX2-5):c.44A>T (p.Lys15Ile)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA212677"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/c429ebe5-43ec-40e7-9d73-55bbbb44f6d1_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c429ebe5-43ec-40e7-9d73-55bbbb44f6d1_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7a2c59b8-4f74-4cc2-94a4-870a73a16703","type":"EvidenceLine","dc:description":"Experts judgement that protein interaction should be downgraded to 0.25 points","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0d73c3d5-c879-4bfe-ad7f-e81d95929734","type":"Finding","dc:description":"BMSCs were transfected with pCMV-HA-NKX2.5 and pCMV-Myc-GATA4 plasmids. Co-immunoprecipitation assay indicated that GATA4 and NKX2.5 can interact with each other in the cells. Bands were detected in the direct input cell lysates, and anti-HA polyclone precipitated cell lysate, while absent in the pre-immune serum precipitated cell lysate, which indicated that NKX2.5 can enable the precipitation of the GATA4 in the cells","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27154817","rdfs:label":"Interaction with GATA4","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.25}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0.25},{"id":"https://genegraph.clinicalgenome.org/r/c429ebe5-43ec-40e7-9d73-55bbbb44f6d1_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/96a70897-eb45-44c9-af3d-4885524e6fec","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a44b4796-8f1f-4f31-a78d-9358cd371dcb","type":"FunctionalAlteration","dc:description":"NKX2-5 mutants failed to bind to most WT targets, including Nppa. The HD mutations result in a severe loss of function. Loss-of-binding of mutant proteins will be associated with alterations in the level of expression of many genes in the cardiac network through haploinsufficiency, which will be a major contributor to the structural and functional heart defects found in human CHD patients","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26146939","rdfs:label":"Bouveret functional alteration"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/c429ebe5-43ec-40e7-9d73-55bbbb44f6d1_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c07becd4-c608-4cc8-a8e4-c8741dab28c1","type":"EvidenceLine","dc:description":"Downgraded as the model doesn't represent the genotypic and phenotypic profile of NKX2.5 related cardiac and myopathic defects","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b796541a-92e4-4e4d-99a8-899f2d6bffc6","type":"Finding","dc:description":"The perinatal loss of Nkx2–5 resulted in rapid conduction and contraction defects within 4 days after the deletion of Nkx2–5 alleles. The mutant hearts were enlarged compared to WT. RT-PCR showed reduction in ventricular expression of the cardiac voltage-gated Na+ channel pore-forming α-subunit (Nav1.5-α), and expression of ryanodine receptor 2, through which Ca2+ is released from sarcoplasmic reticulum. Nkx2–5 function is critical not only during cardiac development, but also in perinatal hearts, by regulating expression of several important gene products involved in conduction and contraction\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18689573","rdfs:label":"Tamoxifen-inducible Nkx2.5 knockout mice model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/d9699612-a6c3-4d29-b9f0-abe489b6ef2e","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f0a6f2d4-0209-4251-8d16-621bc5480e67","type":"Finding","dc:description":"NKX2-5 knockin mouse model faithfully reproduces most characteristics of NKX2-5 mutations in patients and uncovers link between NKX2-5 regulation of the Wnt signaling pathway and late-onset adult CHD. NKX2-5 heterozygous mutants develop adult-onset cardiac dysfunction and reproduce the major clinical characteristics of CHD associated with this gene in patients, including ASD, conduction defects, and noncompacted myocardium. Morphological analysis of adult mutant hearts showed the presence of highly penetrant heart pathology, presented as right ventricle and right atrial dilation and misalignment in relation to the left ventricle. Nkx2-5183P/+ mice displayed increased trabecular layers on the left ventricular wall, indicative of LVNC, commonly observed in patients with NKX2-5 mutations and found in the patient cohort. The homozygous models: Nkx2-5183M/183M or Nkx2-5183P/183P are embryonically lethal and phenocopy-null models.\n\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28352650","rdfs:label":"Knock-in mouse model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/90b929fd-86a0-43ff-b1d7-8deef601a458","type":"EvidenceLine","dc:description":"Downgraded as the model represents a homozygous null model","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bf5cb194-143e-4d14-9462-d2937cc6638d","type":"Finding","dc:description":"Embryos homozygous for the mutant Nkx2-5 allele displayed abnormal hearts at 8.5 days p.c. and died over the next 2 days, apparently from hemodynamic insufficiency. A normal beating linear heart tube formed, but the process of looping morphogenesis was not initiated and had an open atrioventricular chamber, lack of an atrioventricular canal and stepped ventricular-outflow tract junction\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7628699","rdfs:label":"Knock-out mice model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":4.75}],"evidenceStrength":"Definitive","sequence":10111,"specifiedBy":"GeneValidityCriteria9","strengthScore":16.75,"subject":{"id":"https://genegraph.clinicalgenome.org/r/WeJAOcfsQ9Y","type":"GeneValidityProposition","disease":"obo:MONDO_0800441","gene":"hgnc:2488","modeOfInheritance":"obo:HP_0000006"},"version":"2.1","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_c429ebe5-43ec-40e7-9d73-55bbbb44f6d1-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}